3,000
Participants
Start Date
February 28, 2010
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Memorial Sloan-Kettering Cancer Center, New York
New York University Clinical Cancer Center, New York
Roswell Park Cancer Institute, Buffalo
University of Rochester, Rochester
Guthrie Clinic, Ltd, Sayre
Fox Chase Cancer Center, Philadelphia
Washington Cancer Institute at Washington Hospital Center, Washington D.C.
Georgetown University, Washington D.C.
University of Maryland, Baltimore
University of Virginia Health System, Charlottesville
West Virginia University, Morgantown
University of North Carolina Chapel Hill, Chapel Hill
Carolinas Medical Center Northeast, Concord
Carolina Cancer Management, Inc., Fayetteville
Emory University Cancer Center, Atlanta
Georgia Cancer Specialists, Atlanta
Medical College of Georgia, Augusta
MD Anderson Orlando, Orlando
Moffit Cancer Center, Tampa
Coral Springs Oncology, Coral Springs
University of Miami, Miami
Medical Specialists of the Palm Beaches, Lake Worth
Hematology Oncology Associates, Loxahatchee Groves
DCH Cancer Treatment Center, Tuscaloosa
Vanderbilt University Medical Center, Nashville
University of Tennessee Cancer Institute, Memphis
Community Cancer Center, Lorain
Indiana University Simon Cancer Center, Indianapolis
St. Francis Medical Group Oncology and Hematology Associates, Indianapolis
ProMedica, Lambertville
Genesys Hurley Cancer Institute, Flint
Michigan State University, East Lansing
West Michigan Cancer Center, Kalamazoo
University of Wisconsin Comprehensive Cancer Center, Madison
Metro Minnesota Community Clinical Oncology Program, Saint Louis Park
Northwestern University, Chicago
John H. Stroger, Jr. Hospital of Cook County, Chicago
Rush University Medical Center, Chicago
UIC Cancer Center, Chicago
University of Chicago Medical Center, Chicago
Simmons Cooper Cancer Institute at SIU School of Medicine, Springfield
St. Louis University Cancer Center, St Louis
Washington University School of Medicine, St Louis
Research Medical Center, Kansas City
Louisiana State University Health Science Center (LSUHSC), Shreveport
Genesis Cancer Center, Hot Springs
University of Arkansas for Medical Sciences, Little Rock
UT Southwestern, Dallas
Tyler Hematology Oncology, PA, Tyler
Center for Cancer and Blood Disorders, Fort Worth
JPS Center for Cancer Care, Fort Worth
South Texas Oncology and Hematology, P.A., San Antonio
Kootenai Cancer Center, Post Falls
Arizona Cancer Center, Tucson
UCLA, Los Angeles
USC & Norris Cancer Center, Los Angeles
City of Hope National Medical Center, Duarte
UCLA Olive View Medical Center, Sylmar
Wilshire Oncology Medical Group, La Verne
Moores Cancer Center UCSD, La Jolla
Stanford University Medical Center, Stanford
Danbury Hospital Praxair Cancer Center, Danbury
Yale University School of Medicine, New Haven
Boston Medical Center, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Cancer Institute of New Jersey, New Brunswick
Overlook Hospital and Morristown Memorial Hospital, Summit
Lead Sponsor
Acrotech Biopharma Inc.
INDUSTRY